Novi review

The dose model here is the good part, and it is the part Novi states most plainly: same price at every dose, no monthly membership, cancel anytime. On a roster where a rising dose quietly raises the bill at many sellers, that is exactly the structure a low-dose plan needs, and it is committed to in words rather than implied. The pricing is the opposite of plain. Three discount claims share one page and no two agree. The hero strikes through one anchor and lands on a monthly figure. A second hero sitting in the same page's markup, which did not render, strikes through the same anchor and lands on a lower one. A banner offers a flat dollar discount that, taken off that anchor, produces a third number matching neither. And the section you would click Pricing to reach carries no figure for either compounded medication at all — each compounded medication is listed only as an "up to" discount, with the brand-name products carrying a single flat figure and no term. So you can learn what happens to the price when your dose goes up, and you cannot learn what the price is. A countdown headed "Price increases in" showed almost twenty-four hours on a cold load, which is how a permanent banner behaves, not a deadline. No milligram and no pharmacy name appear anywhere on the site.

Vs median

Not comparable — no per-month rate is published — the verified string carries no monthly figure

Market

$59–$1300/mo is the full published spread in our ranking

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not included

Labs

Not required

Pricing

Flat at every dose

Price last updated

August 2026

Novi does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

The dose model is the good part and it is the part this page states most clearly: same price at every dose, no membership, cancel anytime. On a roster where a rising dose quietly raises the bill at many sellers, that is the structure a low-dose reader wants, and Novi commits to it in plain words. The pricing is the opposite. Three different discount claims share one page and no two of them agree: a hero that says $299 becomes $133, a second hero in the same markup that says $299 becomes $99, and a banner offering $140 off, which would make $159. The section a reader would click Pricing to reach carries no price for either compounded medication — only "up to" discounts — and the brand-name products are listed at a flat $1500 with no term. So the dose model is knowable and the price is not, which is an unusual way round: most sellers here publish a number and hide what it buys. A countdown warning that the price increases showed almost twenty-four hours on a cold load, which is how a permanent banner behaves rather than a deadline. No dose and no pharmacy name appear anywhere.

The section labeled Pricing contains no price for either compounded medication.

• Three discount claims on one page do not reconcile with each other or with the $299 anchor.
• A countdown headed "Price increases in" showed almost a full day on a cold load, so it resets.

Novi is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What microdosing GLP-1 costs
• Low dose vs full dose
• The true annual cost of a plan
• What a flat price costs at a low dose